Zhejiang Dayang Biology Technology Co.,Ltd.’s Net Profit Dropped 27.9% in First Three Quarters of 2022

Zhejiang Dayang Biology Technology Co.,Ltd. (浙江大洋生物科技集团股份有限公司) (003017.SZ) reported a net profit of 50.1 million yuan in the first three quarters of 2022, down 27.9% year-on-year.

Meanwhile, the company posted 735.2 million yuan in revenue, up 29.5% year-on-year.

At the end of the reporting period, it had 1.4 billion yuan in total assets and 483.2 million yuan in total liabilities, with a liability-to-asset ratio of 34.5%.